These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2986185)

  • 1. Effects of ethylketocyclazocine on adrenergic transmission in the isolated perfused cat spleen.
    Gaddis RR; Dixon WR
    Pharmacology; 1985; 30(4):205-14. PubMed ID: 2986185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of peripheral adrenergic neurotransmission by methionine-enkephalin.
    Gaddis RR; Dixon WR
    J Pharmacol Exp Ther; 1982 May; 221(2):282-8. PubMed ID: 6281410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen.
    Blakeley AG; Summers RJ
    Br J Pharmacol; 1977 Apr; 59(4):643-50. PubMed ID: 15698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of alpha 2-adrenoceptors permits the operation of otherwise silent opioid kappa-receptors at the sympathetic axons of rabbit jejunal arteries.
    Ramme D; Illes P; Späth L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Sep; 334(1):48-55. PubMed ID: 2878373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors.
    Allgaier C; Daschmann B; Sieverling J; Hertting G
    J Neurochem; 1989 Nov; 53(5):1629-35. PubMed ID: 2552017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests.
    Turkish S; Cooper SJ
    Pharmacol Biochem Behav; 1984 Jul; 21(1):47-51. PubMed ID: 6087378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve stimulation-meditated overflow of norepinephrine and dopamine-beta-hydroxylase. III. Effects of norepinephrine depletion on the alpha presynaptic regulation of release.
    Cubeddu L; Weiner N
    J Pharmacol Exp Ther; 1975 Jan; 192(1):1-14. PubMed ID: 235629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenosine on neurally mediated norepinephrine release from the cat spleen.
    Mueller AL; Mosimann WF; Weiner N
    Eur J Pharmacol; 1979 Feb; 53(4):329-33. PubMed ID: 217696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.
    Gwynn GJ; Domino EF
    J Pharmacol Exp Ther; 1984 Nov; 231(2):306-11. PubMed ID: 6092613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion.
    Carr KD; Bonnet KA; Simon EJ
    Brain Res; 1982 Aug; 245(2):389-93. PubMed ID: 6289969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.
    Slizgi GR; Ludens JH
    J Pharmacol Exp Ther; 1982 Mar; 220(3):585-91. PubMed ID: 6121047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethylketocyclazocine decreases noradrenaline release and blood pressure in the rabbit at a peripheral opioid receptor.
    Ensinger H; Hedler L; Schurr C; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):20-3. PubMed ID: 6096725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new model for the study of opiate B-receptors: isolated splenic strip of the cat.
    Kerecsen L; Knoll J
    Pharmacology; 1981; 22(1):8-14. PubMed ID: 6261270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine release and vascular response elicited by nerve stimulation in rats with chronic neurogenic hypertension.
    Granata AR; Enero MA; Krieger EM; Langer SZ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):187-93. PubMed ID: 6312017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of etorphine on adrenergic neurotransmission in the rat and guinea pig heart.
    Semafuko WE; Follett DL; Dixon WR
    Pharmacology; 1988; 37(3):195-202. PubMed ID: 2852373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prejunctional opioid receptors in the pulmonary artery of the rabbit.
    Seelhorst A; Starke K
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):298-310. PubMed ID: 3019263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen.
    Lundberg JM; Pernow J; Fried G; Anggärd A
    Acta Physiol Scand; 1987 Sep; 131(1):1-10. PubMed ID: 2890260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac slowing induced by peripheral kappa-opiate receptor stimulation in rats.
    Gautret B; Schmitt H
    Eur J Pharmacol; 1984 Jun; 102(1):159-63. PubMed ID: 6148245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.